Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (205)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (6)
2025 (5)
2024 (16)
2023 (30)
2022 (102)
2021 (29)
2020 (50)
2019 (59)
2018 (35)
2017 (50)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (9)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Search

Sponsor content

496 result(s) found, displaying 231 to 240

VORICONAZOLE APO voriconazole 200 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
BTC PREGABALIN pregabalin 150 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
BTC PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
BTC PREGABALIN pregabalin 25 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
BTC PREGABALIN pregabalin 300 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MODAFINIL GH modafinil 100 mg tablet blister pack (311683)

24 January 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MODAFINIL GH modafinil 100 mg tablet blister pack.
AusPAR: Labetalol hydrochloride

12 April 2021

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Labetalol hydrochloride
ERYTHROMYCIN HHH erythromycin (as lactobionate) 1 g powder for injection vial (290145)

24 May 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERYTHROMYCIN HHH erythromycin (as lactobionate) 1 g powder for injection vial.
CON-TGO91-367 - Southern Cross Pharma Pty Ltd

9 November 2020

Section 14, TGO91 consent

Product(s) approved for Supply with noncompliant labelling
TIBOLONE SANDOZ tibolone 2.5 mg tablet blister pack (286596)

4 April 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TIBOLONE SANDOZ tibolone 2.5 mg tablet blister pack.

Pages

First page
Previous page
…
Page 20
Page 21
Page 22
Page 23
Current page 24
Page 25
Page 26
Page 27
Page 28
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.